|
| |
|
|
|
More Tools and information | | Search for suppliers of |  Trade Associations |
|
Newsletters |
Your Gateway to a Fast
Changing World
Product News Alerts |
 |
Receive similar stories and other customized
news to keep you in the know on the products shaping
industry. |
Subscribe Free Today
Subscribe View
Sample |
Industrial
Market Trends
Has Got It |
- Latest developments
- Trends
- Best practices
- Opinions & Commentary
|
 |
Get Ahead.
Get IMT.
Subscribe Free Today
Subscribe View
Sample |
|
|
|
BIO Says Kyl Legislation Advances Patent Reform Debate Biotechnology Industry Organization Release date: September 25, 2008
WASHINGTON, D.C. (September 25, 2008) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the patent reform legislation introduced yesterday by Senator Jon Kyl (R, AZ):
"BIO appreciates the efforts of Senator Kyl and his staff to address the concerns of many stakeholders with the patent reform legislation currently pending in the Senate, and commends him for introducing the Patent Reform Act of 2008. This legislation is a vast improvement over previous bills in the House and Senate with respect to many of the discrete issues and concerns raised by BIO, patient groups, universities, labor unions and many other stakeholders over the past two years.
"In particular, the Kyl legislation advances the debate on damages in a positive direction by enhancing consistent enforcement of the current law on damages and providing greater predictability for companies across all industries - but without manipulating the rules to favor infringers.
"Further, although the post-grant review provisions in the Kyl legislation would provide a second window to administratively challenge a patent, the circumstances allowing such a challenge are considerably more narrow than those in S. 1145, the Patent Reform Act. The broad new administrative challenge system in S. 1145 would create patent uncertainty and reduce investment interest in biotechnology innovation.
"BIO remains committed to working with all Senators and Representatives, their staff, and other stakeholders to reach agreement on how best to improve our nation's patent system in a way that promotes innovation, improves patent quality and increases public participation. The Kyl legislation is an important step forward in enacting patent reform that will benefit the American economy."
Upcoming BIO Events
Intellectual Property Council Committee Fall Conference and Meeting
October 20-22, 2008
Orlando, Fla.
BIO HR Conference 2008
October 26-28, 2008
San Diego, Calif.
BIO-LES Advanced Business Development Course
October 27-29, 2008
San Francisco, Calif.
BIO Investor Forum 2008
October 29-31, 2008
San Francisco, Calif.
Advanced Business Development Course
November 14-16, 2008
Mannheim/Heidelberg, Germany
BIO-Europe 2008
November 17-19, 2008
Mannheim/Heidelberg, Germany
2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Contact:
Stephanie Fischer
(202) 312-9263
Contacts:
General Information:
Stephanie Fischer
USA
Phone: 202-312-9263
Company Information:
Name: Biotechnology Industry Organization
Address: 1201 Maryland Ave., SW, Ste. 900
City: Washington
State: DC
ZIP: 20024
Country: USA
Phone: 202-962-9200
http://bio.org
|
Other News from this company: |
|
|
U.S. Farmers Prefer Biotech Varieties of Corn, Cotton, Soybeans
|
|
|
BIO Comments on White House Letter on Biosimilars
|
|
|
BIO Comments On Medicare Drug Discount Agreement Announced by PhRMA, the White House and Senate Finance Committee
|
|
|
BIO Commends Selection of Kappos to Lead PTO
|
|
|
BIO Commends Senate Committee on Small Business and Entrepreneurship's SBIR Reauthorization
|
|
|
FTC Report on Biosimilars Is Fundamentally Flawed
|
|
|
AARP Biologics Study Based on Fuzzy Math, Flawed Assumptions
|
|
|
BIO Asks EPA To Maintain Flexibility in Life Cycle Analysis for Renewable Fuel Standard
|
|
|
Bio Lauds New NIH Grants Offering Portion of Stimulus Funds to Small R&D Companies
|
|
|
Industry Leaders, Executives to Highlight Biobased Plastics and Chemicals at World Congress on Industrial Biotechnology
|
|
|
2009 BIO International Convention Attracted Global Industry Leaders and Public Officials for Networking, Deal Making and Partnering
|
|
|
Sustainable Farming Provided by Biotech Crops
|
|
|
Jay Keasling Receives Inaugural Biotech Humanitarian Award
|
|
|
Bioscience Education Study Finds Some States Lagging
|
|
|
2009 BIO International Convention to Host US Governors, International Public Officials
|
|
|
BIO Is Confident That Biofuels Can Meet Goals of Renewable Fuel Standard
|
|
|
BIO Elects New Officers, Welcomes 10 New Board Members
|
|
|
Scientific American Worldview Surveys Bio-Innovation Across the Globe
|
|
|
BIO Heads Back to Chicago
|
|
|
The Honourable Dalton McGuinty, Premier of Ontario, Canada, to Receive BIO International Leader Award
|
|
del.icio.us
DIGG
Facebook
Reddit
StumbleUpon
Twitter
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
